Fluorescence Chemicals to Detect Insoluble and Soluble Amyloid-β Aggregates

Donghee Lee, Sung Min Kim, Hye Yun Kim, Youngsoo Kim

Research output: Contribution to journalReview article

2 Citations (Scopus)

Abstract

Misfolded amyloid-β (Aβ) is the key biomarker of Alzheimer's disease (AD), and discoveries of fluorescence chemicals visualizing such Aβ aggregates in the brain have made major contributions in postmortem and antemortem diagnosis of the disorder. Insoluble senile plaques of Aβ in brain tissues are commonly stained with thioflavin and congo red dyes and observed through microscopy, while those in living patient brains are detected via radioisotope-labeled fluorescence chemicals for positron emission tomography. Clinical evidence strongly supports the view that plaques are well-associated with the onset but not with the progression of AD. Plaques could accumulate while cognitive functions of at-risk individuals are still intact, and thus, another biomarker is needed to monitor neurodegeneration. Soluble Aβ oligomers are considered to have strong correlation with neuronal loss and brain atrophy as they are the most neurotoxic forms of misfolded Aβ. However, oligomer-targeting probes encounter several major difficulties in development. There is a significant structural distinction between two Aβ species - plaques are β-sheet-rich while oligomers are unordered - and it is still difficult to isolate and stabilize the oligomeric forms of Aβ. Due to these challenges, soluble oligomer-detecting imaging probes are relatively rare compared to the plaque-targeting chemical probes. This Review describes biochemical and optical characteristics of up-to-date fluorescence chemicals targeting insoluble plaques and soluble oligomers of Aβ. We also highlight the contributions of Aβ fluorescence chemicals to the clinical diagnosis of AD and technical challenges in searching for enhanced imaging probes.

Original languageEnglish
Pages (from-to)2647-2657
Number of pages11
JournalACS Chemical Neuroscience
Volume10
Issue number6
DOIs
Publication statusPublished - 2019 Jun 19

Fingerprint

Oligomers
Amyloid
Fluorescence
Brain
Alzheimer Disease
Biomarkers
Congo Red
Amyloid Plaques
Imaging techniques
Positron emission tomography
Radioisotopes
Positron-Emission Tomography
Cognition
Atrophy
Microscopy
Coloring Agents
Microscopic examination
Tissue

All Science Journal Classification (ASJC) codes

  • Biochemistry
  • Physiology
  • Cognitive Neuroscience
  • Cell Biology

Cite this

Lee, Donghee ; Kim, Sung Min ; Kim, Hye Yun ; Kim, Youngsoo. / Fluorescence Chemicals to Detect Insoluble and Soluble Amyloid-β Aggregates. In: ACS Chemical Neuroscience. 2019 ; Vol. 10, No. 6. pp. 2647-2657.
@article{4bba07b202f5438fb4299547402100a6,
title = "Fluorescence Chemicals to Detect Insoluble and Soluble Amyloid-β Aggregates",
abstract = "Misfolded amyloid-β (Aβ) is the key biomarker of Alzheimer's disease (AD), and discoveries of fluorescence chemicals visualizing such Aβ aggregates in the brain have made major contributions in postmortem and antemortem diagnosis of the disorder. Insoluble senile plaques of Aβ in brain tissues are commonly stained with thioflavin and congo red dyes and observed through microscopy, while those in living patient brains are detected via radioisotope-labeled fluorescence chemicals for positron emission tomography. Clinical evidence strongly supports the view that plaques are well-associated with the onset but not with the progression of AD. Plaques could accumulate while cognitive functions of at-risk individuals are still intact, and thus, another biomarker is needed to monitor neurodegeneration. Soluble Aβ oligomers are considered to have strong correlation with neuronal loss and brain atrophy as they are the most neurotoxic forms of misfolded Aβ. However, oligomer-targeting probes encounter several major difficulties in development. There is a significant structural distinction between two Aβ species - plaques are β-sheet-rich while oligomers are unordered - and it is still difficult to isolate and stabilize the oligomeric forms of Aβ. Due to these challenges, soluble oligomer-detecting imaging probes are relatively rare compared to the plaque-targeting chemical probes. This Review describes biochemical and optical characteristics of up-to-date fluorescence chemicals targeting insoluble plaques and soluble oligomers of Aβ. We also highlight the contributions of Aβ fluorescence chemicals to the clinical diagnosis of AD and technical challenges in searching for enhanced imaging probes.",
author = "Donghee Lee and Kim, {Sung Min} and Kim, {Hye Yun} and Youngsoo Kim",
year = "2019",
month = "6",
day = "19",
doi = "10.1021/acschemneuro.9b00199",
language = "English",
volume = "10",
pages = "2647--2657",
journal = "ACS Chemical Neuroscience",
issn = "1948-7193",
publisher = "American Chemical Society",
number = "6",

}

Fluorescence Chemicals to Detect Insoluble and Soluble Amyloid-β Aggregates. / Lee, Donghee; Kim, Sung Min; Kim, Hye Yun; Kim, Youngsoo.

In: ACS Chemical Neuroscience, Vol. 10, No. 6, 19.06.2019, p. 2647-2657.

Research output: Contribution to journalReview article

TY - JOUR

T1 - Fluorescence Chemicals to Detect Insoluble and Soluble Amyloid-β Aggregates

AU - Lee, Donghee

AU - Kim, Sung Min

AU - Kim, Hye Yun

AU - Kim, Youngsoo

PY - 2019/6/19

Y1 - 2019/6/19

N2 - Misfolded amyloid-β (Aβ) is the key biomarker of Alzheimer's disease (AD), and discoveries of fluorescence chemicals visualizing such Aβ aggregates in the brain have made major contributions in postmortem and antemortem diagnosis of the disorder. Insoluble senile plaques of Aβ in brain tissues are commonly stained with thioflavin and congo red dyes and observed through microscopy, while those in living patient brains are detected via radioisotope-labeled fluorescence chemicals for positron emission tomography. Clinical evidence strongly supports the view that plaques are well-associated with the onset but not with the progression of AD. Plaques could accumulate while cognitive functions of at-risk individuals are still intact, and thus, another biomarker is needed to monitor neurodegeneration. Soluble Aβ oligomers are considered to have strong correlation with neuronal loss and brain atrophy as they are the most neurotoxic forms of misfolded Aβ. However, oligomer-targeting probes encounter several major difficulties in development. There is a significant structural distinction between two Aβ species - plaques are β-sheet-rich while oligomers are unordered - and it is still difficult to isolate and stabilize the oligomeric forms of Aβ. Due to these challenges, soluble oligomer-detecting imaging probes are relatively rare compared to the plaque-targeting chemical probes. This Review describes biochemical and optical characteristics of up-to-date fluorescence chemicals targeting insoluble plaques and soluble oligomers of Aβ. We also highlight the contributions of Aβ fluorescence chemicals to the clinical diagnosis of AD and technical challenges in searching for enhanced imaging probes.

AB - Misfolded amyloid-β (Aβ) is the key biomarker of Alzheimer's disease (AD), and discoveries of fluorescence chemicals visualizing such Aβ aggregates in the brain have made major contributions in postmortem and antemortem diagnosis of the disorder. Insoluble senile plaques of Aβ in brain tissues are commonly stained with thioflavin and congo red dyes and observed through microscopy, while those in living patient brains are detected via radioisotope-labeled fluorescence chemicals for positron emission tomography. Clinical evidence strongly supports the view that plaques are well-associated with the onset but not with the progression of AD. Plaques could accumulate while cognitive functions of at-risk individuals are still intact, and thus, another biomarker is needed to monitor neurodegeneration. Soluble Aβ oligomers are considered to have strong correlation with neuronal loss and brain atrophy as they are the most neurotoxic forms of misfolded Aβ. However, oligomer-targeting probes encounter several major difficulties in development. There is a significant structural distinction between two Aβ species - plaques are β-sheet-rich while oligomers are unordered - and it is still difficult to isolate and stabilize the oligomeric forms of Aβ. Due to these challenges, soluble oligomer-detecting imaging probes are relatively rare compared to the plaque-targeting chemical probes. This Review describes biochemical and optical characteristics of up-to-date fluorescence chemicals targeting insoluble plaques and soluble oligomers of Aβ. We also highlight the contributions of Aβ fluorescence chemicals to the clinical diagnosis of AD and technical challenges in searching for enhanced imaging probes.

UR - http://www.scopus.com/inward/record.url?scp=85065861072&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85065861072&partnerID=8YFLogxK

U2 - 10.1021/acschemneuro.9b00199

DO - 10.1021/acschemneuro.9b00199

M3 - Review article

C2 - 31009195

AN - SCOPUS:85065861072

VL - 10

SP - 2647

EP - 2657

JO - ACS Chemical Neuroscience

JF - ACS Chemical Neuroscience

SN - 1948-7193

IS - 6

ER -